Esaote transducers are designed using advanced manufacturing processes which allow a wide bandwidth to be achieved.
The way in which this bandwidth is utilized is application specific and may cause the transducers to operate at different frequencies on different ultrasound systems.
The following chart lists the frequency bandwidth capability of each transducer independent of system and/or application. Please contact your representative for system specific probe inquiries.
The use of contrast agents in the USA is limited by FDA to left ventricle opacification and visualization of the left ventricular endocardial border.